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functional mobility compared to the highest 25(OH)D quar-
tile (>81 nmol/l); adjusted for all covariates, seniors in the 
highest quartile performed 9.4% better in normal (p = 0.02) 
and 9.2% better in fast (p = 0.004) walking speed, and 4.4% 
better in the TUG test (p = 0.24). The association between 
25(OH)D status and functional mobility was most pro-
nounced in less vulnerable seniors (p for trend significant for 
all three mobility tests). Seniors with a higher 25(OH)D status 
also had better cognitive function (MMSE score; p = 0.006). 
 Conclusions: Lower serum 25(OH)D status is associated with 
poorer functional mobility and cognitive function, therefore 
supporting 25(OH)D assessment in this population at risk for 
both functional and cognitive decline. 
 © 2013 S. Karger AG, Basel 
 Introduction 
 Traditionally, vitamin D has been linked to bone 
health  [1] , and vitamin D supplementation is supported 
as an evidence-based strategy in fracture risk reduction 
among adults aged 65 years and older  [2, 3] . In a most 
recent pooled analysis of source data of 11 double-blind 
randomized controlled trials including 31,022 seniors, vi-
tamin D supplementation at an actual median intake of 
800 IU per day (range 792–2,000) reduced hip fracture 
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 Abstract 
 Background: Recent studies have shown that vitamin D sta-
tus may be relevant for physical and cognitive performance 
in the older population. This association may be of particular 
interest to older people at risk for cognitive impairment and 
functional decline.  Objective: The aim of this study was to 
determine the association between serum 25-hydroxyvita-
min D [25(OH)D] status and functional mobility in seniors as-
sessed in a memory clinic.  Methods: We conducted a cross-
sectional study of outpatients (n = 404) in a memory clinic. 
Functional mobility was assessed with three endpoints: nor-
mal and fast walking speed and the Timed Up and Go (TUG) 
test. Adjusted multivariate analyses in all patients and two 
pre-planned subgroup analyses in vulnerable seniors (previ-
ous fall and MMSE score of  ≥ 26 or no previous fall and MMSE 
score of <26) versus less vulnerable seniors (no previous fall 
and MMSE score of  ≥ 26) were performed to assess the asso-
ciation of 25(OH)D and functional mobility.  Results: Overall, 
mean 25(OH)D serum levels were 63.2 ± 33.9 nmol/l, and 
41.3% were vitamin D deficient (<50 nmol/l). Seniors in the 
lowest 25(OH)D quartile (<39 nmol/l) had significantly worse 
 Received: June 19, 2013 
 Accepted: September 10, 2013 
 Published online: December 7, 2013 
 Dr. phil. Yves J. Gschwind 
 Basel Mobility Center, University Hospital Basel 
 Schanzenstrasse 55 
 CH–4031 Basel (Switzerland) 
 E-Mail y_gschwind   @   bluewin.ch 
 © 2013 S. Karger AG, Basel
0304–324X/13/0602–0123$38.00/0 
 www.karger.com/ger 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
6/
3/
20
16
 1
2:
26
:4
2 
PM
 Gschwind  /Bischoff-Ferrari  /Bridenbaugh  /
Härdi  /Kressig  
 Gerontology 2014;60:123–129 
DOI: 10.1159/000355667
124
risk by 30%  [4] . However, there remains controversy 
about the optimal vitamin D serum level and dose for 
fracture prevention  [5] . Mechanistically, the benefit for 
fracture prevention may be explained by the well-estab-
lished positive effect of vitamin D on calcium absorption 
 [6] . Alternatively, several lines of evidence support a di-
rect effect of vitamin D on muscle  [7, 8] , and several
meta-analyses on trials of vitamin D supplementation 
support vitamin D as an effective strategy in fall preven-
tion  [9, 10] , as reflected in the American and British Ge-
riatric Society Guidelines  [11] . Moreover, vitamin D may 
act on the central nervous system influencing neurophys-
iologic function essential for motor control  [12] . 
 At the same time, the prevalence of vitamin D defi-
ciency is reported to be 50% or more among large parts 
of the senior population worldwide  [13–15] . Serum 
25-hydroxyvitamin D [25(OH)D] represents the best 
clinical measure of systemic vitamin D status  [16] . Se-
niors are at increased risk of vitamin D deficiency due to 
less time spent outside, use of sun protection, less dietary 
intake, and institutionalization  [13, 17] . Furthermore, 
with age, the skin capacity to produce vitamin D from 
UVB exposure is reduced by a factor of 4  [18] . 
 In the general senior population, vitamin D deficiency 
has been associated with reduced muscle strength and 
functional mobility  [19, 20] , as well as a higher risk of 
cognitive decline  [21] , which, in combination, may lead 
to an increased risk of falls, fractures  [22–24] , and nursing 
home admission  [25] . In this large survey of seniors ad-
mitted to a memory clinic, we examined the association 
between vitamin D status and functional mobility. We 
hypothesized that serum 25(OH)D acts as a mediator of 
improved functional mobility and that there is an asso-
ciation between vitamin D and cognition in seniors as-
sessed at a memory clinic. Further, we explored whether 
these associations differ between less vulnerable and vul-
nerable seniors. 
 Subjects and Methods 
 Study Population 
 Data from 579 consecutive memory clinic patients at risk for 
cognitive and functional decline assessed in an ambulatory setting 
between September 2008 and April 2011 were screened for eligibil-
ity. A total of 175 patients were excluded from the data analysis, 
because they fulfilled at least one of the following exclusion crite-
ria: younger than 65 years of age, use of walking aid, or missing 
data [25(OH)D, normal or fast walking speed, age, gender, height, 
weight, Mini-Mental State Examination (MMSE) score, number of 
prescription drugs, or Timed Up and Go (TUG) results]. Data 
from the remaining 404 patients were analyzed for this study. This 
study was approved by the local ethics committee (Canton Basel, 
reference number EK 365/11).
 The examination battery applied at the Memory Clinic of the 
University Hospital Basel included the MMSE (the maximum 
score is 30 points: 0–10 = severe cognitive impairment; 11–20 = 
moderate cognitive impairment; 21–26 = mild cognitive impair-
ment, and 27–30 = normal cognitive function) as a measure of 
global cognitive function  [26] and a functional mobility assess-
ment (measurements of TUG and gait analysis) at the Basel Mobil-
ity Center. Further, a physical examination was performed by a 
physician, including recording of height and weight, the medical 
history, and the number of prescription drugs taken (self-report, 
report from caregivers, and/or documented medical history). We 
used the latter as a surrogate for comorbidity. In addition, the phy-
sician explored the history of falls in the previous 12 months, in-
cluding observations by accompanying caregivers. A fall was de-
fined according to the Prevention of Falls Network Europe (Pro-
FaNE) as ‘an unexpected event in which the participant comes to 
a rest on the ground, floor, or lower level’  [27] . Further, blood was 
drawn by nurses at the Memory Clinic for the assessment of 
25(OH)D status and other relevant biomarkers.
 We defined less vulnerable and vulnerable individuals based on 
their cognitive performance in the MMSE and previous fall his-
tory (in the last 12 months)  [28] . Less vulnerable seniors had no 
previous fall and a MMSE score of  ≥ 26. Vulnerable seniors either 
had a previous fall and an MMSE score of  ≥ 26 or had no previous 
fall and a MMSE score of <26.
 Functional Mobility Assessment 
 For functional mobility, three tests were evaluated: normal and 
fast walking speed, and the TUG test. Patients wore their normal 
clothes, their own shoes, and a safety belt. The test administrator 
walked beside and slightly behind the patient to provide assistance 
and grab the safety belt if balance loss occurred while walking. 
 Normal and Fast Walking Speed 
 A 972 cm long electronic walkway with integrated pressure 
sensors (GAITRite ® Gold and Platinum, CIR Systems, Sparta, 
N.J., USA) was used for gait analyses according to the European 
guidelines for clinical applications of spatiotemporal gait analysis 
in older adults  [29] . Detailed testing procedures have previously 
been described by Bridenbaugh and Kressig  [30] . Patients were 
verbally instructed regarding the gait analysis testing procedure: 
first, they had to walk at their usual speed (self-selected pace) and 
then as fast as possible (fast walking, but not running). No practice 
walks were performed before testing. Each walk was performed 
once. 
 Timed Up and Go Test 
 The TUG assesses basic mobility in seniors and was conducted 
at the Basel Mobility Center prior to the walking speed assessments 
 [31] . When performing the TUG, the time in seconds that it takes 
an individual to rise from an armchair with armrests, walk 3 m at 
their regular walking speed, turn, walk back, and sit down again is 
measured using a stop watch. 
 Serum 25(OH)D Assay 
 Blood samples for the determination of 25(OH)D concentra-
tions were obtained by a nurse from the Memory Clinic and ana-
lyzed at the Laboratory of Immunology at the University Hospi-
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tal Basel. An automated enzyme immune assay analyzer named 
DSX (Dynex Technologies, Chantilly, Va., USA) was used for 
25(OH)D quantification in human serum. Samples were diluted 
with biotin-labeled 25(OH)D and incubated in microtiter wells. 
Enzyme-labeled avidin was added and bound selectively to com-
plexed biotin followed by developing color using a chromogenic 
substrate. The absorbance of the stopped reaction mixtures was 
read in a microtiter plate reader, whereby the color intensity is in-
versely proportional to the concentration of 25(OH)D. The intra-
assay and inter-assay coefficients of variation for 25(OH)D were 
5.3 and 4.6%, respectively  [32] . 
 Statistical Analyses  
 The baseline characteristics of the 404 memory clinic patients 
were summarized using means and standard deviations or fre-
quencies and percentages, as appropriate, in all, in less vulnerable 
(no previous fall and a MMSE score of  ≥ 26) and vulnerable (previ-
ous fall and a MMSE score of  ≥ 26 or no previous fall and a MMSE 
score of <26) seniors, and by quartile of 25(OH)D status. Serum 
25(OH)D levels were assessed as quartiles (<39, 39–54, 55–81, and 
>81 nmol/l). General linear models were performed to evalu-
ate differences in walking speed (normal and fast) and TUG by 
25(OH)D quartile for all, less vulnerable and vulnerable seniors 
adjusted for age, gender, body mass index (BMI), MMSE, number 
of prescription drugs, and previous falls (yes/no). Analyses were 
conducted with SAS version 9.2 (SAS Institute, Cary, N.C., USA) 
software. All p values are two-sided. 
 Results 
 A total of 404 memory clinic patients (mean age 77.6 
± 5.8 years, 53.5% female) were included in this survey. 
 Table 1 describes important covariates of the study popu-
lation by vulnerability and quartile of 25(OH)D status. 
The overall mean MMSE score was 24.5 ± 4.1 points 
(range 5–30). Altogether, 37.4% (n = 151) of seniors took 
>5 prescription drugs, 28.2% (n = 114) took between 3 
and 5, and 34.4% (n = 139) took <3. 
 25(OH)D Status 
 Mean 25(OH)D status was 63.2 ± 33.9 nmol/l; 4.7%
(n = 19) had serum levels <25 nmol/l (severe deficiency), 
41.3% (n = 134) had levels <50 nmol/l (deficiency), and 
69.8% (n = 282) had levels <75 nmol/l (threshold for op-
timal fall and fracture reduction)  [33] . Seniors with high-
er 25(OH)D status had a significantly higher MMSE score 
(p = 0.006). 
 Association between 25(OH)D Status and Functional 
Mobility in All Seniors 
 At the univariate level, seniors in the lowest 25(OH)D 
quartile (<39 nmol/l) had significantly worse functional 
mobility performance for all three functional mobility 
measures (normal and fast walking speed and TUG) 
when compared to the highest 25(OH)D quartile (>81 
nmol/l). There was a pattern that suggested that all se-
niors in 25(OH)D quartile levels >39 nmol/l had an equal-
ly better function than those in the lowest quartile. This 
pattern was maintained for all functional mobility mea-
sures also in the multivariate analyses after adjustment 
for age, gender, BMI, MMSE, prescription drugs, and
falls ( fig.  1 ). We found no linear association between 
25(OH)D and walking speed.
Table 1.  Characteristics of memory clinic patients aged 65 years and older by vulnerability status and by quartile of 25(OH)D status
Characteristics All
(n = 404)
Less 
vulnerable
patients
(n = 322)
Vulnerable
patients
(n = 82)
pa Serum 25(OH)D level quartile pb
1 
<39 nmol/l
(n = 101)
2
39 – 54 nmol/l
(n = 97)
3
55 – 81 nmol/l
(n = 105)
4
>81 nmol/l
(n = 101)
Serum 25(OH)D, nmol/l 63.2 ± 33.9 65.3 ± 34.4 55.1 ± 30.8 0.02 29.8 ± 6.1 46.2 ± 4.9 66.2 ± 7.4 109.9 ± 30.1 <0.001
Age, years 77.6 ± 5.8 77.1 ± 5.8 79.1 ± 5.4 0.005 78.9 ± 5.6 78.0 ± 5.8 76.2 ± 5.8 77.2 ± 5.5 0.005
BMI, kg/m2 25.2 ± 4.9 25.4 ± 4.0 24.1 ± 3.3 0.002 25.7 ± 4.2 25.2 ± 4.0 25.7 ± 3.9 24.0 ± 3.3 0.004
MMSE score 24.5 ± 4.1 25.4 ± 3.6 20.8 ± 4.2 <0.001 23.4 ± 4.4 24.4 ± 4.2 24.6 ± 4.0 25.4 ± 3.8 0.006
Prescription drugs, n 3.7 ± 2.6 3.9 ± 2.7 3.7 ± 2.6 0.594 3.7 ± 2.7 3.6 ± 2.5 3.9 ± 2.8 4.1 ± 2.7 0.46
TUG, s 12.1 ± 3.3 11.8 ± 3.0 13.3 ± 4.0 0.002 12.9 ± 3.2 12.0 ± 3.3 11.8 ± 3.2 11.8 ± 3.2 0.06
Normal walking speed,
cm/s 110.0 ± 22.7 117.7 ± 22.9 103.2 ± 20.8 0.003 102.3 ± 21.6 110.8 ± 23.4 113.5 ± 22.0 113.3 ± 22.2 <0.001
Fast walking speed, 
cm/s 150.3 ± 31.6 153.9 ± 31.1 136.1 ± 30.0 <0.001 137.3 ± 27.8 151.9 ± 32.9 155.3 ± 31.5 156.6 ± 30.6 <0.001
Data are means ± standard deviation. a Differences between groups were assessed using Student’s t test. b Differences between 25(OH)D
quartiles were assessed using analysis of variance.
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 Association between 25(OH)D Status and Functional 
Mobility in Less Vulnerable and Vulnerable Seniors 
 Compared to vulnerable seniors, less vulnerable se-
niors (no previous fall and MMSE  ≥ 26) showed a more 
pronounced association between all three functional mo-
bility measures and 25(OH)D quartile level. Notably, in 
the subgroup of less vulnerable seniors, the pattern of as-
sociation changed from a threshold of 39 nmol/l as ob-
served in the total study population to a trend for better 
performance with higher 25(OH)D status. In less vulner-
able seniors, this trend was significant for normal and fast 
walking speed and TUG performance ( fig. 2 ).
 Discussion 
 In this large survey of 404 consecutive ambulatory 
memory clinic patients aged 65 years and older, low se-
rum 25(OH)D status was not only associated with a low-
er MMSE score, but also with decreased functional mobil-
ity. Including both less vulnerable and vulnerable seniors 
as defined by their cognitive status and prior fall status, a 
25(OH)D threshold of 39 nmol/l (upper end of the lowest 
quartile) was suggested for better functional mobility. 
However, in the subgroup of less vulnerable seniors (n = 
322), there was a significant trend for better functional 
mobility (normal and fast walking speed and TUG) with 
a higher 25(OH)D quartile status, with a desirable thresh-
old of >81 nmol/l for optimal functional mobility.
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 Fig. 1. Functional performance by quartile of 25(OH)D status in 
all 404 seniors. Normal walking speed ( a ), fast walking speed ( b ), 
and TUG performance ( c ) for all seniors by 25(OH)D quartile. We 
show least square means and the standard error around the least 
square means, adjusted for age, gender, BMI, MMSE score, num-
ber of prescription drugs, and fall history in the last 12 months 
(yes/no). For all three tests, individuals in the lowest quartile of 
25(OH)D status (<39 nmol/l) performed worse. 
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 Vitamin D has been linked to cognitive performance 
in seniors  [34] . In a retrospective study of older patients 
assessed in a memory clinic, 25(OH)D status was posi-
tively correlated with the MMSE  [35] . Another recent 
study evaluated the effects of vitamin D supplementation 
on cognition in seniors referred to a memory clinic and 
reported a 25(OH)D-associated improvement in MMSE 
score  [36] . Our study confirms these findings, docu-
menting a significant association between a higher 
25(OH)D level and better cognitive performance as-
sessed with the MMSE in seniors examined at a memory 
clinic. 
 Several previous studies  [37] , including EPIDOS (Epi-
démiologie de l’Ostéoporose)  [38] , the Cardiovascular 
Health All Stars study  [19] , and the population-based 
NHANES III study  [7] , support an inverse association be-
tween higher 25(OH)D status and faster walking speed 
among community-dwelling seniors. The benefit of vita-
min D supplementation (800–1,000 IU) on TUG perfor-
mance was recently confirmed in a meta-analysis among 
seniors aged 60 years and older  [39] . Our study extends 
to seniors assessed in a memory clinic, supporting at the 
cross-sectional level a positive association between higher 
25(OH)D status and functional mobility, including TUG 
and gait performance.
 In the present study, 41.3% of individuals were vitamin 
D deficient and 69.8% did not reach the desirable thresh-
old of 75 nmol/l for fall and fracture prevention  [33] . 
These data are consistent with international reports 
where about 50% of ambulatory seniors are expected to 
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 Fig. 2. Functional performance by quartile of 25(OH)D status in 
less vulnerable (n = 322) and vulnerable seniors (n = 82). Normal 
walking speed ( a ), fast walking speed ( b ), and TUG performance 
( c ) for less vulnerable (filled marker) and vulnerable (open mark-
er) by 25(OH)D quartile. We show least square means and the 
standard error around the least square means, adjusted for age, 
gender, BMI, MMSE score, number of prescription drugs, and fall 
history in the last 12 months (yes/no). There was a significant trend 
between quartiles of 25(OH)D status and functional mobility for 
all three tests of functional performance among less vulnerable se-
niors with a desirable threshold of >81 nmol/l for optimal gait and 
TUG performance. Such a trend could not be documented in vul-
nerable seniors. In vulnerable seniors, individuals in the lowest 
quartile had worse gait at a normal and fast pace compared to in-
dividuals in higher quartiles. For TUG performance, we could not 
document a significant association with 25(OH)D status among 
vulnerable seniors. 
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have vitamin D deficiency  [13, 14] , and about 70% fall 
below a threshold of 75 nmol/l  [4, 7] .
 As a surprise to the authors, less vulnerable seniors (no 
previous fall and MMSE  ≥ 26) expressed a more linear as-
sociation between 25(OH)D quartile status and gait and 
functional mobility with a desirable 25(OH)D threshold 
of >81 nmol/l for optimal performance. Comparing ex-
treme quartiles in less vulnerable seniors, the threshold of 
>81 nmol/l was associated with an about 11% better per-
formance in gait (normal and fast) and TUG compared 
to the lowest 25(OH)D quartile (<39 nmol/l). Our expec-
tation was that vulnerable seniors may be more suscep-
tible to 25(OH)D status. However, including these se-
niors, only the lowest quartile was associated with worse 
functional mobility compared to the other quartiles, sug-
gesting a lower threshold of 39 nmol/l. This may be ex-
plained by an added level of impairment by a previous fall 
or reduced cognitive function, which may camouflage a 
positive association between 25(OH)D status and func-
tional mobility.
 Our study has several strengths. We measured 25(OH)D
status, gait, and the TUG in a standardized way in a large 
consecutive sample of memory clinic patients. The con-
sistency across the three tests applied lends credibility to 
our findings as does the observed pattern of association 
in all participants and most pronounced in less vulnerable 
participants. Notably, our findings are adjusted for key 
covariates, including age, gender, BMI, cognitive func-
tion, number of prescription drugs, and previous fall (yes/
no). A further strength of our study is its population, 
which extends previous findings concerning individuals 
at risk of cognitive and functional decline assessed at a 
memory clinic setting. Our study also has several limita-
tions. A key limitation is its cross-sectional design where 
interpretation is limited to associations rather than cau-
sality. Although we were able to adjust for important con-
founders, we may have missed others, such as physical 
activity, exercise, and skeletal muscle mass. However, 
physical activity is likely to be on the causal pathway be-
tween 25(OH)D and gait performance, which would have 
disqualified its inclusion in our analyses. Notably, expo-
sure to sunlight, seasonal variations, body fat, dietary and 
supplement intake of vitamin D are reflected in the 
25(OH)D status.
 In summary and according to our findings, a higher 
25(OH)D status seems to contribute to better normal and 
fast walking speed, as well as quicker TUG performance 
in seniors referred to a memory clinic. Notably, this pos-
itive association may be most pronounced in less vulner-
able seniors, and a desirable threshold for optimal func-
tion in this subgroup may be >81 nmol/l. For the whole 
population assessed, also including vulnerable seniors, it 
seemed important for functional mobility to avoid a 
25(OH)D status <39 nmol/l. Our data support measure-
ment of 25(OH)D status in memory clinic patients, also 
for the observed positive association between higher 
25(OH)D status and better cognitive performance.
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